Early research (Phase 1)Ended earlyNCT02795325
What this trial is testing
DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)
Who this might be right for
Primary Hyperoxaluria Type 1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 41
Showing 20 of 41 results